Displaying items by tag: department of medicine

These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1.
The study, funded by the Patient-Centered Outcomes Research Institute, will compare two pathways of post-fracture patient care.
Some PD-1+CXCR5+CD4+ T cells will become germinal center-Tfh cells that are essential for B cells to become high-affinity antibody-producing cells. Others do not take that path, instead becoming memory T cells.
$46 million awarded by NIH to UAB and partners allows researchers to continue following participants enrolled in the national Multicenter Osteoarthritis Study.
The newly introduced kidney function equation has value in predicting heart failure comparable to the old equation but may reduce racial disparities by improving access to heart failure therapy among Black heart failure patients.
Today the National Institutes of Health has announced that UAB’s own Jeanne Marrazzo, M.D., has been selected to succeed Anthony Fauci, M.D., as the next director of NIH’s National Institute of Allergy and Infectious Diseases (NIAID) this fall. 
The future has much potential as the REACH Up and Out program hopes to continue to make an impact on the lives of Black women in the Deep South.
Chronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
UAB researchers conducted a study including approximately 20,000 left ventricular assist device recipients and found that women had worse clinical outcomes compared with men across social and clinical subgroups of interest.

The NIH grants will fund two studies evaluating the role of behavioral, geographic and demographic vulnerabilities in relation to HIV acquisitions among cis- and transgender women in the South.
Page 3 of 36